Navigation Links
Newly revised guidelines for managing thyroid cancer published in Thyroid journal
Date:11/5/2009

New Rochelle, NY, November 5, 2009The American Thyroid Association has released new, revised Management Guidelines for the diagnosis and treatment of patients with thyroid nodules and thyroid cancer. The new guidelines are published in Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). Thyroid is the official journal of the American Thyroid Association (ATA). The ATA's revised Management Guidelines and accompanying editorials are available free online at www.liebertpub.com/thy

The ATA Guidelines Taskforce updated and revised the initial management guidelines it released in 2006 because of the large number of new clinical research findings that have been published in the last three years. Thyroid nodules continue to be a common clinical problem, and the prevalence of differentiated thyroid cancer is rapidly increasing.

For managing thyroid nodules, the guidelines focus on the initial presentation, clinical and ultrasound evaluation, the decision to perform fine-needle biopsy and how to interpret the results, and the management of benign thyroid nodules.

The revised guidelines for managing thyroid cancer provide recommendations for optimal surgical management, the use of radioiodine remnant ablation, thyroid hormone suppression therapy, as well as long-term surveillance based on ultrasound, other imaging modalities, and laboratory testing.

Accompanying the Management Guidelines published in Thyroid are four editorials that include commentary on the preparation of the revised guidelines, highlights of the 2009 revisions, the transition from consensus- to evidence-based best practices, and a surgical perspective. The editorials were written by Charles H. Emerson, MD, Editor-in-Chief of Thyroid and Professor Emeritus of Medicine at the University of Massachusetts School of Medicine, in Worcester; Leonard Wartofsky, MD, from Washington Hospital Center (District of Columbia); jointly by Efisio Puxeddu, MD, PhD, from University of Perugia, and Sebastiano Filetti, MD, from University of Rome, Italy; and jointly by Dana Hartl, MD, PhD, and Jean-Paul Travagli, MD, from Institut Gustave Roussy, Villejuif, France.

"The Taskforce worked very hard to draft guidelines that were clinically relevant and evidence-based. We hope that they will provide a framework for the care of patients with nodular thyroid disease and thyroid cancer that will be accepted throughout the world," said David S. Cooper, MD, ATA Guidelines Taskforce Chair and Professor of Medicine at Johns Hopkins University (Baltimore, MD).

"The newly revised ATA Task Force Guidelines are a worthy successor to the original guidelines published in 2006. They will be carefully scrutinized by clinical investigators and used on a daily basis by physicians as they evaluate thyroid nodules and manage thyroid cancer," said Charles H. Emerson, MD.

"Guidelines should be designed to guide, and this revision signals the maturation of internationally well received advice on the management of patients with potentially serious disease. Nobody should underestimate the danger of badly managed thyroid cancer and this American Thyroid Association Task Force has produced a first class guide for practitioners," said Terry Davies, MD, President of the American Thyroid Association and Florence and Theodore Baumritter Professor of Medicine, Mount Sinai School of Medicine (New York, NY).


'/>"/>

Contact: Julia Chapman
jchapman@liebertpub.com
914-740-2147
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Related medicine news :

1. First study examines newly-licensed RN work attitudes and intentions
2. Common abdominal pain may be due to a potentially treatable newly recognized inflammatory reaction
3. Higher death rates in kidney patients with newly recognized disease
4. Newly Published Study in Leading Medical Journal Further Confirms the Brava Systems Non-Surgical Breast Enhancement Effectiveness
5. Natural Nutrition Expands Revenue Capabilities with Newly Installed State of the Art Nutrition Bar Line
6. Corrected & Replaced - Natural Nutrition Expands Revenue Capabilities with Newly Installed State of the Art Nutrition Bar Line
7. Hidden Costs Plague Owners Occupying Newly Constructed Buildings; New Program Can Help Avoid Major Issues
8. Striking shift seen among newly HIV-infected men regarding partners
9. Newly HIV-Infected Gay Men Select Other Infected Partners
10. Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
11. New therapeutic options for newly diagnosed multiple myeloma patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... As part of its ongoing series of ... Each webinar features a dynamic expert and thoughtful presentation to give attendees a ... facilities. Both events are free to attend, but registration is required. ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency care to stabilize ... can leave patients with dental emergencies at risk of losing a tooth or their ... care. , Common dental emergencies include:, , Avulsed or ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s 2016 Executive ... than 200 of the country’s top healthcare executives to share insights on transformational ... of the Forum is the provider-centric perspective, experience, expertise and strategy shared by ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... award winner and inspirational speaker Jan Fox will serve as keynote speaker at ... will provide participants with tools to more effectively communicate with their own organizational ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined ... readily available to physicians. The integration will enable Allscripts users to post open ... Everseat’s free mobile app. , The partnership gives Everseat substantial added power to ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- CSI Specialty Group (CSI) expanded its specialty pharmacy ... Pharmacy Podcast. A free, weekly show, the Specialty Pharmacy ... discussion and context amongst specialty pharmacy peers and professionals. ... The Specialty Pharmacy Podcast, hosted by industry leader ... DiMascio, CHE, CMCE, CPC, is available for streaming and/or ...
(Date:2/10/2016)... and SAN DIEGO , Feb. 10, ... global leader in viral gene therapy manufacturing, and Renova™ ... congestive heart failure and other chronic diseases, have entered ... manufacturing process and produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product ... --> --> This relationship ...
(Date:2/10/2016)... -- Urologix, the market leader for in-office minimally invasive ... (BPH), announces new private ownership and is operating as ... industry veteran of more than 20 years, has been ... Plymouth, Minn. The company,s two ... RF Therapy, will continue to be broadly available and ...
Breaking Medicine Technology: